Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3
Read MoreAvance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3
Read MoreAvance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards – Biotech Company of the Year Private
Read MoreAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for
Read MoreAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to
Read MoreAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to
Read MoreAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global
Read MoreAvance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma
Read MoreAvance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific
Read MoreThe largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical
Read MoreThe leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today
Read More